Skip to main content

PAPEL DE LAS NUCLEOTIDOHIDROLASAS EN LA PRESERVACION DE LA INTEGRIDAD GENOMICA EN TRYPANOSOMA BRUCEI

PID2019-109623RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Establishment of a screening platform based on human coronavirus OC43 for the identification of microbial natural products with antiviral activity

  • Martínez-Arribas, Blanca
  • Annang, Frederick
  • Díaz-González, Rosario
  • Pérez-Moreno, Guiomar
  • Martín, Jesús
  • Mackenzie, Thomas
  • Castillo, Francisco
  • Reyes, Fernando
  • Genilloud, Olga
  • Ruiz-Pérez, Luis Miguel
  • Vicente, Francisca
  • Ramos, María C.
  • González-Pacanowska, Dolores
Human coronaviruses (HCoVs) cause respiratory tract infections and are of great importance due to the recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Human betacoronavirus OC43 (HCoV-OC43) is an adequate surrogate for SARS-CoV-2 because it infects the human respiratory system, presents a comparable biology, and is transmitted in a similar way. Its use is advantageous since it only requires biosafety level (BSL)-2 infrastructure which minimizes costs and biosafety associated limitations. In this report, we describe a high-throughput screening (HTS) platform to identify compounds that inhibit the propagation of HCoV-OC43. Optimization of assays based on inhibition of the cytopathic effect and virus immunodetection with a specific antibody, has provided a robust methodology for the screening of a selection of microbial natural product extracts from the Fundación MEDINA collection. Using this approach, a subset of 1280 extracts has been explored. Of these, upon hit confirmation and early LC-MS dereplication, 10 extracts were identified that contain potential new compounds. In addition, we report on the novel antiviral activity of some previously described natural products whose presence in bioactive extracts was confirmed by LC/MS analysis., This work was funded by the the European Commission—Next Generation EU (regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global), the Instituto de Salud Carlos III Subdirección General de Redes y Centros de Investigación Cooperativa-Red de Investigación Cooperativa en Enfermedades Tropicales (RICET: RD16/0027/0014), the MCIN/AEI/10.13039/501100011033 (PID2019-109623RB-I00), the MCIN/AEI/10.13039/501100011033 and FEDER Una manera de hacer Europa (2016-79957-R) and by the Junta de Andalucía (BIO-199), No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Inosine triphosphate pyrophosphatase from Trypanosoma brucei cleanses cytosolic pools from deaminated nucleotides

  • Vidal, Antonio E.
  • Yagüe-Capilla, Miriam
  • Martínez-Arribas, Blanca
  • García-Caballero, Daniel
  • Ruiz-Pérez, Luis Miguel
  • González-Pacanowska, Dolores
Inosine triphosphate pyrophosphatases (ITPases) are ubiquitous house-cleaning enzymes that specifically recognize deaminated purine nucleotides and catalyze their hydrolytic cleavage. In this work, we have characterized the Trypanosoma brucei ITPase ortholog (TbITPA). Recombinant TbITPA efficiently hydrolyzes (deoxy)ITP and XTP nucleotides into their respective monophosphate form. Immunolocalization analysis performed in bloodstream forms suggests that the primary role of TbITPA is the exclusion of deaminated purines from the cytosolic nucleoside triphosphate pools. Even though ITPA-knockout bloodstream parasites are viable, they are more sensitive to inhibition of IMP dehydrogenase with mycophenolic acid, likely due to an expansion of IMP, the ITP precursor. On the other hand, TbITPA can also hydrolyze the activated form of the antiviral ribavirin although in this case, the absence of ITPase activity in the cell confers protection against this nucleoside analog. This unexpected phenotype is dependant on purine availability and can be explained by the fact that ribavirin monophosphate, the reaction product generated by TbITPA, is a potent inhibitor of trypanosomal IMP dehydrogenase and GMP reductase. In summary, the present study constitutes the first report on a protozoan inosine triphosphate pyrophosphatase involved in the removal of harmful deaminated nucleotides from the cytosolic pool., This work was funded by the Instituto de Salud Carlos III Subdirección General de Redes y Centros de Investigación Cooperativa-Red de Investigación Cooperativa en Enfermedades Tropicales (RICET: RD16/0027/0014), the MCIN/AEI/10.13039/501100011033 (PID2019-109623RB-I00), the MCIN/AEI/10.13039/501100011033 and FEDER Una manera de hacer Europa (2016-79957-R) and by the Junta de Andalucía (BIO-199)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Repurposing the Open Global Health Library for the discovery of novel Mpro destabilizers with scope as broad-spectrum antivirals

  • Castillo, Francisco
  • Ramírez, David
  • Ramos, María C.
  • Martínez-Arribas, Blanca
  • Domingo-Contreras, Elisabeth
  • Mackenzie, Thomas
  • Peña-Varas, Carlos
  • Lindemann, Sven
  • Montero, Fernando
  • Annang, Frederick
  • Vicente, Francisca
  • Genilloud, Olga
  • González-Pacanowska, Dolores
  • Fernández-Godino, Rosario
The SARS coronavirus 2 (SARS-CoV-2) epidemic remains globally active. The emergence of new variants of interest and variants of concern (VoCs), which are potentially more vaccine-resistant and less sensitive to existing treatments, is evident due to their high prevalence. The prospective spread of such variants and other coronaviruses with epidemic potential demands preparedness that can be met by developing fast-track workflows to find new candidates that target viral proteins with a clear in vitro and in vivo phenotype. Mpro (or 3CLpro) is directly involved in the viral replication cycle and the production and function of viral polyproteins, which makes it an ideal target. The biological relevance of Mpro is highly conserved among betacoronaviruses like HCoV-OC43 and SARS-CoV-2, which makes the identification of new chemical scaffolds targeting them a good starting point for designing broad-spectrum antivirals. We report an optimized methodology based on orthogonal cell-free assays to identify small molecules that inhibit the binding pockets of both SARS-CoV-2-Mpro and HCoV-OC43-Mpro; this blockade correlates with antiviral activities in HCoV-OC43 cellular models. By using such a fast-tracking approach against the Open Global Health Library (Merck KGaA), we have found evidence of the antiviral activity of compound OGHL98. In silico studies dissecting intermolecular interactions between OGHL98 and both proteases and comprising docking and molecular dynamics simulations (MDSs) concluded that the binding mode was primarily governed by conserved H-bonds with their C-terminal amino acids and that the rational design of OGHL98 has potential against VoCs proteases resistant to current therapeutics., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. DG-P’s laboratory and research have been funded by the European Commission—Next Generation EU (regulation EU 2020/2094) through CSIC’s Global Health Platform (PTI Salud Global), the Instituto de Salud Carlos III Subdirección General de Redes y Centros de Investigación Cooperativa-Red de Investigación Cooperativa en Enfermedades Tropicales (RICET: RD16/0027/0014), and the MCIN/AEI/10.13039/501100011033, and by the grants PID2019-109623RB-I00, MCIN/AEI/10.13039/501100011033, and FEDER Una manera de hacer Europa (2016- 79957-R), and PID2022-142971OB-I00, MCIN/AEI/10.13039/501100011033/FEDER, UE, and by the Junta de Andalucía (BIO-199). DR’s research has been funded by the Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT), grant number 1220656, and the Agencia Nacional de Investigación y Desarrollo (ANID), grant number COVID0199., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A cytidine deaminase-like protein modulates pyrimidine nucleotide homeostasis in Trypanosoma brucei

  • Moro-Bulnes, Ana
  • Bosch-Navarrete, Cristina
  • Antequera-Parrilla, Pablo
  • Castanys, Santiago
  • Vidal, Antonio E.
  • Ruiz-Pérez, Luis Miguel
  • Pérez-Moreno, Guiomar
  • González-Pacanowska, Dolores
Pyrimidine nucleotide homeostasis is critical for DNA replication and cell viability, yet its regulation in Trypanosoma brucei, the causative agent of African trypanosomiasis, remains poorly understood. Here, we characterize a T. brucei cytidine deaminase-like protein (TbCDA-like), a kinetoplastid-specific enzyme absent in mammals, that harbors a deaminase domain and a zinc-finger CCCH motif. Using RNA interference (RNAi) and overexpression approaches, we demonstrate that TbCDA-like modulates pyrimidine nucleotide pools, influencing both ribonucleotide and deoxyribonucleotide profiles. Overexpression of TbCDA-like resulted in a substantial reduction of dCTP and CTP levels while elevating dTTP and UTP pools, suggesting a role in cytidine derivative deamination. Conversely, RNAi-mediated depletion of TbCDA-like caused CMP accumulation and reduced dTTP levels. Notably, overexpression induced severe cytotoxicity, growth arrest, DNA damage and cell cycle defects, evidenced by sub-G1 populations, increased nuclear H2A phosphorylation and aberrant kinetoplast and nuclear morphologies. Localization studies revealed that TbCDA-like is primarily cytosolic and relocalizes to stress granules upon nutrient deprivation, suggesting a role in RNA metabolism. These findings establish TbCDA-like as a key regulator of pyrimidine nucleotide homeostasis in T. brucei, linking nucleotide imbalances to DNA replication stress and genome instability. Given its absence in mammals, TbCDA-like presents an attractive target for therapeutic intervention against trypanosomiasis., We thank the TrypTag database for the available information regarding the subcellular localization of TbCDA-like. This work was funded by grant PID2019-109623RB-I00 and PID2021-124911OB-I00, the MCIN/AEI/https://doi.org/10.13039/501100011033 and FEDER Una manera de hacer Europa (2016-79957-R), grant PID2022-142971OB-I00 MCIN/ AEI / https://doi.org/10.13039/501100011033 / ERDF, UE and by the Junta de Andalucía (BIO-199). A.M.B. was supported by a Formación del Profesorado Universitario (Ref FPU15/01820) fellowship from the Spanish Government (Ministerio de Educación y Formación Profesional). P. A-P. was supported by a “Formación de Doctores” (BES-2017-082012) fellowship from the Spanish Government (Ministerio de Ciencia e Innovación)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Bovistols E and F, New bis-Sesquiterpenes Isolated From Psathyrella microrhiza CF-117891

  • Annang, Frederick
  • Pérez-Moreno, Guiomar
  • Bosch-Navarrete, Cristina
  • González-Menendez, Víctor
  • Fernández Martín, Jesús
  • Pérez-Bonilla, Mercedes
  • Ruiz-Pérez, Luis Miguel
  • Genilloud, Olga
  • González-Pacanowska, Dolores
  • Vicente, Francisca
  • Reyes, Fernando
Bioactivity-based purification of the acetone extract of a culture of the fungus Psathyrella microrhiza CF-117891 led to the isolation of the new bis-sesquiterpenes bovistols E and F (1 and 2) together with the anti-plasmodial coriolic acid (3). The structures of the new compounds isolated were determined by a combination of positive electrospray ionization time-of-flight mass spectrometry and nuclear magnetic resonance spectroscopy. Of the three compounds isolated, coriolic acid displayed previously unreported moderate anti-Plasmodium falciparum 3D7 activity, with a half-maximal effective concentration value of 17.8 µM, whereas the new bovistols did not show any biological activity in their pure forms against this parasite nor against Trypanosoma cruzi Tulahuen parasites., This work was funded by the Instituto de Salud Carlos III Subdirección General de Redes y Centros de Investigación Cooperativa-Red de Investigación Cooperativa en Enfermedades Tropicales (RICET: RD16/0027/0014, RD16/0027/0015, and RD12/0018/0005), the Plan Nacional (SAF PID2019-109623RB-I00; SAF2016-79957-R) and by the Junta de Andalucía (BIO-199). The polarimeter, HPLC, IR, NMR equipment and plate reader used in this work were purchased via grants for scientific and technological infrastructures from the Ministerio de Ciencia e Innovación [Grants Nos. PCT- 010000-2010-4 (NMR), INP-2011-0016-PCT-010000 ACT6 (polarimeter, HPLC, and IR), and PCT-01000-ACT7, 2011-13 (plate reader and liquid-handling systems)]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Optimization of Physicochemical Properties and ADME for 2,4-Substituted 1H-Pyrrolo[2,3b]pyridines Inhibitors of Trypanosome Proliferation

  • Bachovchin, Kelly
  • Díaz, Rosario
  • Ceballos-Pérez, Gloria
  • Rojas-Barros, Domingo I.
  • Pérez-Moreno, Guiomar
  • García-Hernández, Raquel
  • Bosch-Navarrete, Cristina
  • Rivers, Mitch
  • Penn, Erica C.
  • Roncal, Norma E.
  • Sciotti, Richard J.
  • Campbell, Robert F.
  • Martínez-Martínez, María S.
  • Manzano, Pilar
  • Ruiz-Pérez, Luis Miguel
  • Navarro, Miguel
  • González-Pacanowska, Dolores
  • Pollastri, Michael P.
  • Ferrins, Lori
  • Singh, Baljinder
Neglected tropical diseases, such as human African trypanosomiasis (HAT), require novel treatments that can populate the clinical pipeline in the event of rising resistance and treatment recrudescence. Following a high-throughput screen of almost 42,000 human kinase inhibitor chemotypes, we identified a 2,4-disubstituted azaindole that had good antiparasitic activity, selectivity, and predicted brain exposure, but that failed to meet our criteria for advancement into an efficacy study. Following hit-to-lead optimization, we arrived at 18a, which offered the best combination of potency, properties, and pharmacokinetic parameters, and, while not curative, this work leads to opportunities for continued optimization for HAT and cutaneous leishmaniasis., The authors acknowledge funding from the National Institute of Allergy and Infectious Diseases (M.P.P., M.N. D.G.-P., and L.F., 2R01AI114685; M.P.P., 1R21AI127594, R01AI124046), the Spanish Ministerio de Economía, Industria y Competitividad, (M.N., SAF2015-71444 P; D.G.-P., PID2019-109623RB-I00 MICIU/AEI/10.13039/501100011033 and PID2022-142971OB-I00 MCIN/AEI/10.13039/501100011033/ERDF, UE), and Subdirección General de Redes y Centros de Investigación Cooperativa (RICET) (M.N., RD16/0027/0019; D.G.-P., RD16/0027/0014). We thank AstraZeneca for the provision of the in vitro ADME and physicochemical properties data included in the manuscript. Use of JChem/ChemAxon software [Product version 20.11.0, ChemAxon (https://www.chemaxon.com)] is acknowledged., Peer reviewed